GlassScriptPhysician profile
Aniko Arms
NPI 1225420656
$609.32
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $540 · 2024: $69.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $251.88 | 2023-2024 | |
| Eisai INC. | $123.97 | 2023 | |
| Pfizer INC. | $42.93 | 2023 | |
| Kyowa Kirin, INC. | $39.67 | 2023 | Nourianz |
| Lilly USA, LLC | $32.38 | 2023 | Amyvid |
| Ucb, INC. | $27.54 | 2023 | Briviact |
| Takeda Pharmaceuticals U.S.A., INC. | $27.53 | 2023 | |
| Sumitomo Pharma America, INC. | $19.05 | 2023 | Aptiom |
| Upsher-Smith Laboratories LLC | $18.07 | 2023 | |
| Amneal Pharmaceuticals LLC | $13.60 | 2023 | Rytary |
| Teva Pharmaceuticals USA, INC. | $12.70 | 2023 | Austedo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aniko Arms listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.